3654 results for «308»

Filter By

3654 results

Clinical cases - Coronary interventions - Session 1

06 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 3

06 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 2

06 Oct 2022 – From AICT-AsiaPCR 2022

Abstracts - Coronary interventions - Session 2

06 Oct 2022 – From AICT-AsiaPCR 2022

Abstracts - Coronary interventions - Session 3

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 4

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 5

07 Oct 2022 – From AICT-AsiaPCR 2022

Outcome of women in different cardiovascular interventions

06 Oct 2022 – From AICT-AsiaPCR 2022

Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation

15 Mar 2021

The aim of this study was to investigate the prognostic value of thermodilution-derived coronary flow capacity (T-CFC) in patients with stable coronary artery disease and deferred revascularisation.

Authors :

Masahiro Hoshino, Yoshihisa Kanaji, Rikuta Hamaya, Yoshinori Kanno, Masahiro Hada, Masao Yamaguchi, Yohei Sumino, Eisuke Usui, Tadashi Murai, Tetsumin Lee, Taishi Yonetsu, Tsunekazu Kakuta
EuroIntervention: Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation

Jupiter Endovascular announces positive results from SPIRARE I first-in-human study presented at TCT 2025

26 Oct 2025

Primary left ventricular unloading in anterior STEMI without cardiogenic shock: Results from the STEMI-Door to Unload randomized clinical trial

28 Mar 2026

Elad Asher provides his take on the STEMI-DTU trial, which was presented by Navin K. Kapur at the ACC.26 in New Orleans, and simultaneously published in the JACC.

Elad Asher

Author

Elad Asher
Primary left ventricular unloading in anterior STEMI without cardiogenic shock: Results from the STEMI-Door to Unload randomized clinical trial

FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE coronary intravascular lithotripsy catheter meets primary safety and effectiveness endpoints

18 May 2026

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?